INCOME STATEMENT
Solara Active Pharma Sciences Ltd.
BSE
Apr 30
493.65
-19.30 ( -3.76%)
Volume
9784
Prev. Close
512.95
Open Price
512.95
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Apr 30
493.85
-19.05 ( -3.71%)
Volume
113724
Prev. Close
512.90
Open Price
515.45
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Income Statement
for the last 5 years.
|
ISIN No
|
INE624Z01016
|
Market Cap. ( ₹ in Cr. )
|
1987.94
|
P/BV
|
1.83
|
Book Value ( ₹ )
|
270.47
|
|
BSE Code
|
541540
|
52 Week High/Low ( ₹ )
|
883/367
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
NSE Code
|
SOLARAEQ
|
Book Closure
|
20/09/2024
|
EPS ( ₹ )
|
0.00
|
Div Yield (%)
|
0.00
|
(₹ in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 1238.39 | 1379.19 | 1230.55 | 1575.73 | 1267.64 |
| Other Operating Revenues | 50.53 | 64.62 | 37.79 | 41.15 | 54.11 |
| Total Operating Revenues | 1288.92 | 1443.81 | 1268.34 | 1616.88 | 1321.75 |
| | | | | | |
| Other Income | 5.37 | 22.14 | 18.76 | 28.41 | 27.51 |
| Total Revenue | 1294.29 | 1465.95 | 1287.10 | 1645.29 | 1349.26 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 760.65 | 773.90 | 858.86 | 683.76 | 623.36 |
| Purchase Of Stock-In Trade | 5.10 | 7.88 | 53.78 | 42.80 | 29.67 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 39.27 | 7.05 | -258.75 | -2.15 | -54.16 |
| Employee Benefit Expenses | 243.92 | 228.05 | 234.20 | 227.63 | 202.24 |
| Finance Costs | 105.97 | 90.06 | 75.27 | 84.47 | 77.88 |
| Depreciation And Amortisation Expenses | 103.03 | 110.90 | 112.01 | 108.31 | 93.67 |
| Other Expenses | 335.04 | 292.89 | 299.90 | 279.51 | 264.11 |
| Total Expenses | 1592.98 | 1510.73 | 1375.27 | 1424.33 | 1236.77 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -298.69 | -44.78 | -88.17 | 220.96 | 112.49 |
| | | | | | |
| Exceptional Items | -189.64 | 0.00 | -3.49 | 0.00 | 0.00 |
| Profit/Loss Before Tax | -488.33 | -44.78 | -91.66 | 220.96 | 112.49 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 0.00 | -0.11 | 0.00 | 38.64 | 20.69 |
| Deferred Tax | 78.54 | -22.46 | -33.10 | -38.64 | -20.69 |
| Total Tax Expenses | 78.54 | -22.57 | -33.10 | 0.00 | 0.00 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -566.87 | -22.21 | -58.56 | 220.96 | 112.49 |
| | | | | | |
| Profit/Loss From Continuing Operations | -566.87 | -22.21 | -58.56 | 220.96 | 112.49 |
| | | | | | |
| Profit/Loss For The Period | -566.87 | -22.21 | -58.56 | 220.96 | 112.49 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | -157.48 | -6.17 | -16.29 | 68.86 | 43.47 |
| Diluted EPS (Rs.) | -157.48 | -6.17 | -16.29 | 68.86 | 42.03 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 0.00 | 10.78 | 19.74 | 15.66 |
| Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 70.00 | 20.00 |